| A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer B Farran, G Dyson, D Craig, A Dombkowski, JL Beebe-Dimmer, IJ Powell, ... Carcinogenesis 39 (4), 556-561, 2018 | 29 | 2018 |
| Adiponectin in Gastrointestinal Malignancies B Farran, IZ Atiquah, D Park Novel therapeutic approaches for gastrointestinal malignancies, 31-42, 2020 | | 2020 |
| An update on the physiological and therapeutic relevance of GPCR oligomers B Farran Pharmacological research 117, 303-327, 2017 | 117 | 2017 |
| and Ganji Purnachandra Nagaraju G Srivani, B Dariya, B Farran, A Alam Exploring Pancreatic Metabolism and Malignancy, 1, 2019 | | 2019 |
| Aquaporins in female specific cancers P Kasa, B Farran, GLV Prasad, GP Nagaraju Gene 700, 60-64, 2019 | 14 | 2019 |
| Are Nanocarriers Effective for the Diagnosis and Treatment of Pancreatic Cancer? P Kasa, B Farran, GSR Raju Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy …, 2019 | 4 | 2019 |
| BBI-608 modulates DNA repair pathways, induces apoptosis and impacts response to 5-Fluorouracil and ionizing radiation in pancreatic cancer cells B Farran, GP Nagaraju, SG Shipra, SR Bethi, GB Lesinski, B El-Rayes Cancer Research 79 (13_Supplement), 713-713, 2019 | | 2019 |
| BBI-608 modulates stemness, angiogenesis and enhances the efficacy of chemoradiotherapy in pre-clinical models of pancreatic cancer GP Nagaraju, MR Farren, S Govardhanagiri, SR Bethi, B Farran, ... Cancer Research 79 (13_Supplement), 354-354, 2019 | | 2019 |
| Biology of Pancreas and Possible Diseases G Srivani, B Dariya, B Farran, A Alam, GP Nagaraju Exploring Pancreatic Metabolism and Malignancy, 1-25, 2019 | | 2019 |
| Breaking the stromal barrier in pancreatic cancer: Advances and challenges M Chakkera, JB Foote, B Farran, GP Nagaraju Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 189065, 2023 | 1 | 2023 |
| Computational analysis of nuclear factor-κB and resveratrol in colorectal cancer B Dariya, SK Behera, G Srivani, B Farran, A Alam, GP Nagaraju Journal of Biomolecular Structure and Dynamics 39 (8), 2914-2922, 2021 | 11 | 2021 |
| Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates HK Verma, B Farran, LVKS Bhaskar Antibody Therapeutics 3 (2), 115-125, 2020 | 24 | 2020 |
| Correlative analysis of metformin and nivolumab combination in treatment-refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC) B Farran, JM Switchenko, L Khalil, WL Shaib, B Olson, A Ruggieri, C Wu, ... Cancer Research 82 (12_Supplement), 3482-3482, 2022 | | 2022 |
| Current clinical trials for epigenetic targets and therapeutic inhibitors for pancreatic cancer therapy C Ganji, B Farran Drug Discovery Today 27 (5), 1404-1410, 2022 | 7 | 2022 |
| Developing a recombinant model of the P2Y1 and P2Y11 receptor interactions mediating relaxation in gut smooth muscle B Farran UCL (University College London), 2015 | | 2015 |
| Exosomes as therapeutic solutions for pancreatic cancer B Farran, GP Nagaraju Drug Discovery Today 25 (12), 2245-2256, 2020 | 9 | 2020 |
| Folate-conjugated nanovehicles: Strategies for cancer therapy B Farran, RC Montenegro, P Kasa, E Pavitra, YS Huh, YK Han, MA Kamal, ... Materials Science and Engineering: C 107, 110341, 2020 | 80 | 2020 |
| Folate-targeted immunotherapies: Passive and active strategies for cancer B Farran, E Pavitra, P Kasa, S Peela, GSR Raju, GP Nagaraju Cytokine & growth factor reviews 45, 45-52, 2019 | 40 | 2019 |
| Gastric cancer management: kinases as a target therapy B Farran, S Müller, RC Montenegro Clinical and Experimental Pharmacology and Physiology 44 (6), 613-622, 2017 | 37 | 2017 |
| Horizons of nanotechnology applications in female specific cancers B Rajitha, RR Malla, R Vadde, P Kasa, GLV Prasad, B Farran, S Kumari, ... Seminars in cancer biology 69, 376-390, 2021 | 43 | 2021 |
